alphaveNECLIFE₹11.90

Nectar Lifesciences Limited

₹ CrorePeersAAREYDRUGS NATCAPSUQ MEDICAMEQ MEDICO BALPHARMA ALPA KREBSBIO HALEOSLABSMcap ₹231 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	590.3	576.6	103.4	103.4
+ Capital Work-in-Progress	65.7	56.7	0.0	0.0
+ Goodwill	0.0	0.0	1.1	1.1
+ Other Intangibles	52.4	56.5	0.0	0.0
+ Non-current Investments	0.2	0.2	0.2	0.2
+ Long-term Loans	0.0	0.0	0.1	0.1
+ Trade Receivables — Non-current	8.2	8.5	0.0	0.0
+ Other Non-current Financial Assets	2.8	3.3	2.9	2.9
Non-current Financial Assets	11.2	12.0	3.2	3.2
+ Deferred Tax Assets	7.5	55.0	224.5	224.5
+ Other Non-current Assets	180.1	52.8	0.6	0.6
Total Non-current Assets	907.2	809.6	332.8	332.8
Current Assets
+ Inventories	709.2	690.2	0.3	0.3
+ Current Investments	0.5	0.5	13.0	13.0
+ Trade Receivables	379.2	345.5	0.0	0.0
+ Cash & Cash Equivalents	19.8	19.2	0.0	0.0
+ Other Bank Balances	0.0	0.0	112.1	112.1
+ Short-term Loans	0.9	0.9	0.1	0.1
+ Other Current Financial Assets	9.2	7.5	66.0	66.0
Current Financial Assets	409.6	373.6	191.2	191.2
+ Other Current Assets	165.0	173.8	61.5	61.5
Total Current Assets	1,283.8	1,237.6	253.0	253.0
Total Assets	2,191.1	2,047.2	621.6	621.6
Equity
+ Equity Share Capital	22.4	22.4	19.4	19.4
+ Other Equity / Reserves	1,046.8	933.7	562.9	562.9
Equity — Owners of Parent	1,069.2	956.1	582.3	582.3
Total Equity	1,069.2	956.1	582.3	582.3
Liabilities
+ Borrowings — Non-current	140.3	60.1	0.0	0.0
+ Other Non-current Financial Liab	—	—	9.2	9.2
Non-current Financial Liabilities	140.3	60.1	9.2	9.2
+ Provisions — Non-current	7.9	8.7	0.0	0.0
+ Other Non-current Liabilities	0.7	0.7	—	—
Non-current Liabilities	149.0	69.6	9.2	9.2
+ Borrowings — Current	495.2	521.9	0.0	0.0
+ Trade Payables	419.7	438.1	0.0	0.0
+ Other Current Financial Liab	38.7	49.8	25.7	25.7
Current Financial Liabilities	953.6	1,009.8	25.7	25.7
+ Provisions — Current	2.2	2.9	0.0	0.0
+ Other Current Liabilities	17.0	8.8	0.3	0.3
Current Liabilities	972.8	1,021.5	26.1	26.1
Total Liabilities	1,121.8	1,091.1	39.3	39.3
Total Equity & Liabilities	2,191.1	2,047.2	621.6	621.6
Assets — additional as-filed lines
+ Non-current Assets Held for Sale	0.0	—	35.9	35.9
Liabilities — additional as-filed lines
+ Liabilities of Disposal Group Held for Sale	0.0	—	4.1	4.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	8.8	0.0	0.0
+ Dues to Other Creditors — Current	—	429.4	0.0	0.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.